Shares of Emcure Pharmaceuticals jumped 10% to ₹2,180.80 on Wednesday, November 4, scaling a record high after gaining 5% in the previous session. The stock has rallied 16% in just two trading sessions following the pharmaceutical company's strong September quarter results (Q2FY27).
Robust revenue and profit growth, improving business prospects across domestic and international markets, and positive brokerage commentary have strengthened investor sentiment towards the stock.
Emcure Pharma shares touched a record high of ₹2,180.80 apiece on the BSE. The stock has now gained 67% from its 52-week low of ₹1,307.50, recorded in November 2025.
The stock has delivered strong returns across time periods, rising 12% in one month, 10% in three months, 21% in six months and 64% over the past year.
Emcure Pharmaceuticals reported a 29.3% year-on-year (YoY) increase in adjusted profit after tax (PAT) to ₹325.1 crore in Q2FY27 compared with ₹251.4 crore in the corresponding quarter last year.